Quanterix Names Dr. Yuri Fesko Chief Medical Officer

/in , /by

BILLERICA, Mass. — Quanterix Corporation (Nasdaq: QTRX), a global leader in precision biomarker science, today announced that accomplished physician executive Dr. Yuri Fesko has been appointed Chief Medical Officer of the company. In this new role, he will provide medical and clinical leadership across Quanterix, partnering closely with the company’s Diagnostics, Scientific, R&D, Regulatory, and […]

Read more →

Molecular Devices and STEMCELL Technologies Collaborate to Accelerate Adoption of Human-Relevant Organoid Models Through Automation

/in , , , /by

Validated on the CellXpress.ai® Automated Cell Culture System, the new workflow combines organoid biology expertise and laboratory automation to help researchers reduce variability, expand scale, and move discoveries toward impact with greater confidence SAN JOSE, Calif. and VANCOUVER, BC – Molecular Devices, a Danaher company and a leading provider of high-performance life science solutions, and STEMCELL […]

Read more →

Lunit Announces Collaboration with 10x Genomics to Integrate AI-Enabled Pathology Analysis with Spatial Molecular Data for Oncology Clinical Research

/in , /by

10x Genomics, a leader in single-cell and spatial biology, to combine its spatial biology technologies with Lunit’s AI-powered H&E pathology analysis to advance oncology biomarker discovery SEOUL, South Korea — Lunit (KRX: 328130), a leading provider of AI for cancer diagnostics and precision oncology, today announced that 10x Genomics, Inc. (Nasdaq: TXG) will incorporate Lunit’s […]

Read more →

Partillion Bioscience Secures $2.1 Million NIH SBIR Grant to Advance Large-Scale Cell-Cell Interaction Sequencing

/in , /by

Tenth SBIR award brings Partillion’s total non-dilutive federal funding to more than $8 million and supports development of Cell-Cell-seq workflows LOS ANGELES — Partillion Bioscience announced a two-year, $2.1 million NIH Small Business Innovation Research (SBIR) award from the National Institute of General Medical Sciences (NIGMS) to expand the company’s Cell-Cell-seq workflows. Partillion’s 10th SBIR […]

Read more →

Emulate Enters Final Stage of FDA ISTAND Program for Human Liver-Chip with Submission of Qualification Package Covering Both Zoë® and AVA™ Organ-Chip Platforms

/in , , , /by

Submission marks the first time data from the AVA™ Emulation System will be evaluated as part of the FDA qualification process, reinforcing confidence in scalable human-relevant liver models BOSTON — Emulate, Inc., the leading provider of next-generation Organ-on-a-Chip technology, today announced it has submitted its FDA Innovative Science and Technology Approaches for New Drugs (ISTAND) […]

Read more →

Bracco Expands BubbleGen Cell Selection with CD3+ T Cell Isolation Kit

/in , , , , , /by

Microbubble-based technology enables magnetic bead-free cell selection for cell therapy research and development PRINCETON, N.J. — Bracco Imaging, a global pharmaceutical company that develops, manufactures, and markets innovative healthcare solutions, today announced the expansion of its BubbleGen™ cell selection portfolio with the launch of the BubbleGen CD3+ T Cell Selection Kit. The kit, built on […]

Read more →

Countable Labs Continues Global Expansion with New Japanese Distributor

/in , /by

Countable Labs’ full portfolio is now available through distribution agreement with PRIMETECH PALO ALTO, Calif. — Countable Labs, developer of Countable PCR, a next-generation PCR technology that enables direct, single-molecule quantification, today announced a distribution partnership with PRIMETECH Corporation to bring its full portfolio of Countable PCR-based solutions to customers in Japan. The agreement follows […]

Read more →

Beckman Coulter Life Sciences Launches Vi-CELL BLU 2.0 Software to Advance Data Integrity and GMP Readiness in Cell Analysis

/in , /by

Next-generation upgrade strengthens data comparability and compliance—without changing trusted instrumentation San Jose – Beckman Coulter Life Sciences, a Danaher company and a global leader in laboratory automation and innovation, today announced the launch of Vi-CELL BLU 2.0 Viability Analyzer Software, a major upgrade that enables laboratories to modernize cell viability workflows while maintaining data continuity, […]

Read more →

VION Biosciences Expands Integrated Platform Across Biopharma Services and Diagnostic Workflow Capabilities

/in , , , , , /by

Acquisition adds regulated bioanalytical and CMC services, diagnostic reagents, and workflow critical products to support translational, clinical, and commercial development SHAKER HEIGHTS, Ohio — VION Biosciences (“VION”), a life sciences company building integrated capabilities across research, diagnostics, and drug development workflows, today announced the closing of its acquisition of Prolytix, a provider of regulated bioanalytical […]

Read more →

Revvity to Acquire Human Cell Design to Advance Human-Relevant Cell Models for Metabolic Disease Drug Discovery

/in , , , /by

Acquisition strengthens Revvity’s position in human-relevant life sciences tools for next-generation GLP-1 and GPCR-targeting therapies for metabolic drug discovery Combines HCD’s human pancreatic beta cell models with Revvity’s capabilities in cell analysis, detection, high-content screening and gene editing Expands Revvity’s ability to support customers across the research-to-clinic continuum, including emerging applications in clinical development and […]

Read more →